{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:16:17Z","timestamp":1775607377890,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.sapharm.2019.11.008","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:34:16Z","timestamp":1574296456000},"page":"1100-1110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Studying the impact of a medication use evaluation by the community pharmacist (Simenon): Drug-related problems and associated variables"],"prefix":"10.1016","volume":"16","author":[{"given":"Joke","family":"Wuyts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joris","family":"Maesschalck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"De Wulf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e9lanie","family":"Lelubre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrien","family":"Foubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carine","family":"De Vriese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koen","family":"Boussery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geert","family":"Goderis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"De Lepeleire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veerle","family":"Foulon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2019.11.008_bib1","series-title":"Polypharmacy Management by 2030: A Patient Safety Challenge","author":"Mair","year":"2017"},{"issue":"2","key":"10.1016\/j.sapharm.2019.11.008_bib2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11096-017-0581-9","article-title":"The scope of drug-related problems in the home care setting","volume":"40","author":"Meyer-Massetti","year":"2018","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.sapharm.2019.11.008_bib3","series-title":"Classification for Drug Related Problems (v6.2)","author":"Pharmaceutical Care Network Europe","year":"2010"},{"issue":"17","key":"10.1016\/j.sapharm.2019.11.008_bib4","first-page":"1890","article-title":"Frequency of and risk factors for preventable medication-related hospital admissions in The Netherlands","volume":"168","author":"Leendertse","year":"2008","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.sapharm.2019.11.008_bib5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1023\/A:1015570104121","article-title":"Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies","volume":"24","author":"Beijer","year":"2002","journal-title":"Pharm World Sci"},{"issue":"2","key":"10.1016\/j.sapharm.2019.11.008_bib6","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/bcp.12293","article-title":"A systematic review of hospitalization resulting from medicine-related problems in adult patients","volume":"78","author":"Al Hamid","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.sapharm.2019.11.008_bib7","series-title":"IMS Health Report: Advancing the Responsible Use of Medicines in Belgium - Applying Levers for Change","author":"IMS Institute for Healthcare Informatics","year":"2015"},{"key":"10.1016\/j.sapharm.2019.11.008_bib8","series-title":"Position Paper on the PCNE Definition of Medication Review","author":"Pharmaceutical Care Network Europe","year":"2016"},{"key":"10.1016\/j.sapharm.2019.11.008_bib9","author":"NHS Employers"},{"issue":"1","key":"10.1016\/j.sapharm.2019.11.008_bib10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/bcp.12140","article-title":"A systematic review and meta-analysis of pharmacist-led fee-for-services medication review","volume":"77","author":"Hatah","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.sapharm.2019.11.008_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2050312116652568","article-title":"The effect of pharmacist-led interventions in optimising prescribing in older adults in primary care: a systematic review","volume":"4","author":"Riordan","year":"2016","journal-title":"SAGE Open Med"},{"issue":"2","key":"10.1016\/j.sapharm.2019.11.008_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008986.pub2","article-title":"Medication review in hospitalised patients to reduce morbidity and mortality","author":"Christensen","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.sapharm.2019.11.008_bib13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2318-11-79","article-title":"Inappropriate medication use among the elderly: a systematic review of administrative databases","volume":"11","author":"Guaraldo","year":"2011","journal-title":"BMC Geriatr"},{"issue":"8","key":"10.1016\/j.sapharm.2019.11.008_bib14","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/j.1532-5415.2011.03497.x","article-title":"Airaksinen MS a, Kivel\u00e4 S-L, Lyles A, Leikola SNS. Comparison of prescribing criteria to evaluate the appropriateness of drug treatment in individuals aged 65 and older: a systematic review","volume":"59","author":"Dimitrow","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.sapharm.2019.11.008_bib15","author":"Pharmaceutical Society of New Zealand Incorporated"},{"issue":"1","key":"10.1016\/j.sapharm.2019.11.008_bib16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12913-016-1384-8","article-title":"Impact of a community pharmacist-led medication review on medicines use in patients on polypharmacy - a prospective randomised controlled trial","volume":"16","author":"Messerli","year":"2016","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.sapharm.2019.11.008_bib17","author":"Pharmaceutical Society of Australia"},{"key":"10.1016\/j.sapharm.2019.11.008_bib18","author":"Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie (KNMP)"},{"key":"10.1016\/j.sapharm.2019.11.008_bib19","author":"Center for Medicare"},{"issue":"572","key":"10.1016\/j.sapharm.2019.11.008_bib20","first-page":"37","article-title":"Le bilan de m\u00e9dication en soins primaires chez les plus de 65 ans","volume":"57","author":"Qassemi","year":"2018","journal-title":"Actual Pharmacol"},{"key":"10.1016\/j.sapharm.2019.11.008_bib21","author":"Belgische Federale Overheid"},{"key":"10.1016\/j.sapharm.2019.11.008_bib22","series-title":"Polyfarmacie Bij Ouderen [Polypharmacy in Aged Patients]","author":"Belgisch Rijksinstituut voor Ziekte- en Invaliditeitsverzekering (RIZIV)","year":"2014"},{"issue":"1","key":"10.1016\/j.sapharm.2019.11.008_bib23","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1186\/s12913-018-3440-z","article-title":"Studying the impact of a medication use evaluation for polymedicated older patients by the community pharmacist (SIMENON): study protocol","volume":"18","author":"Wuyts","year":"2018","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"10.1016\/j.sapharm.2019.11.008_bib24","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1093\/pubmed\/fdv090","article-title":"Older patients' prescriptions screening in the community pharmacy: development of the Ghent Older People's Prescriptions community Pharmacy Screening (GheOP3S) tool","volume":"38","author":"Tommelein","year":"2016","journal-title":"J Public Health"},{"key":"10.1016\/j.sapharm.2019.11.008_bib25","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1111\/jep.12817","article-title":"Documentation of pharmaceutical care: validation of an intervention oriented classification system","volume":"23","author":"Maes","year":"2017","journal-title":"J Eval Clin Pract"},{"issue":"1","key":"10.1016\/j.sapharm.2019.11.008_bib26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11096-015-0189-x","article-title":"Bondesson \u00c5. Medication reviews in primary care in Sweden: importance of clinical pharmacists' recommendations on drug-related problems","volume":"38","author":"Modig","year":"2016","journal-title":"Int J Clin Pharm"},{"issue":"5","key":"10.1016\/j.sapharm.2019.11.008_bib27","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s11096-015-0145-9","article-title":"Implementation of medication review with follow-up in a Spanish community pharmacy and its achieved outcomes","volume":"37","author":"Ocampo","year":"2015","journal-title":"Int J Clin Pharm"},{"issue":"9","key":"10.1016\/j.sapharm.2019.11.008_bib28","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/jgs.13597","article-title":"Drug-related-problem outcomes and program satisfaction from a comprehensive brown bag medication review","volume":"63","author":"O'Connell","year":"2015","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"10.1016\/j.sapharm.2019.11.008_bib29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.sapharm.2013.04.008","article-title":"Pharmacists\u2019 performance of clinical interventions during adherence support medication reviews","volume":"10","author":"Hatah","year":"2014","journal-title":"Res Soc Adm Pharm"},{"issue":"10","key":"10.1016\/j.sapharm.2019.11.008_bib30","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1177\/1060028014543485","article-title":"The impact of medication reconciliation and review on clinical outcomes","volume":"48","author":"Lehnbom","year":"2014","journal-title":"Ann Pharmacother"},{"issue":"8","key":"10.1016\/j.sapharm.2019.11.008_bib31","doi-asserted-by":"crossref","first-page":"522","DOI":"10.47671\/TVG.75.08.2002829","article-title":"Evaluatie van een elektronisch beslissingsondersteunend programma voor optimalisatie van het medicatieschema bij ambulante ouderen","volume":"75","author":"Luyssen","year":"2019","journal-title":"Tijdschr Geneeskd"},{"issue":"Suppl 1","key":"10.1016\/j.sapharm.2019.11.008_bib32","first-page":"A1","article-title":"The effect of a Geriatric Stewardship on drug-related problems after discharge","volume":"26","author":"Ponjee","year":"2019","journal-title":"Eur J Hosp Pharm"},{"issue":"2","key":"10.1016\/j.sapharm.2019.11.008_bib33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40266-012-0048-6","article-title":"The relationship between the extent of collaboration of general practitioners and pharmacists and the implementation of recommendations arising from medication review: a systematic review","volume":"30","author":"Kwint","year":"2013","journal-title":"Drugs Aging"},{"issue":"6","key":"10.1016\/j.sapharm.2019.11.008_bib34","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s11096-007-9130-2","article-title":"Exploring elements of interprofessional collaboration between pharmacists and physicians in medication review","volume":"29","author":"Chen","year":"2007","journal-title":"Pharm World Sci"},{"issue":"12","key":"10.1016\/j.sapharm.2019.11.008_bib35","article-title":"Implementation study of an intermediate medication review in Belgian community pharmacies","author":"Lelubre","year":"2018","journal-title":"Res Soc Adm Pharm"},{"issue":"5","key":"10.1016\/j.sapharm.2019.11.008_bib36","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.sapharm.2014.02.005","article-title":"Medication review practices in European countries","volume":"10","author":"Bulajeva","year":"2014","journal-title":"Res Soc Adm Pharm"},{"issue":"10","key":"10.1016\/j.sapharm.2019.11.008_bib37","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/phar.1462","article-title":"Predictors of medication-related problems among medicaid patients participating in a pharmacist-provided telephonic medication therapy management program","volume":"34","author":"Snyder","year":"2014","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.sapharm.2019.11.008_bib38","first-page":"1","article-title":"Community pharmacists' evaluation of potentially inappropriate prescribing in older community-dwelling patients with polypharmacy: observational research based on the GheOP3S tool","volume":"39","author":"Tommelein","year":"2016","journal-title":"J Public Health"},{"issue":"10","key":"10.1016\/j.sapharm.2019.11.008_bib39","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.jamda.2018.06.010","article-title":"Potentially inappropriate prescribing in Belgian nursing homes: prevalence and associated factors","volume":"19","author":"Anrys","year":"2018","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"10.1016\/j.sapharm.2019.11.008_bib40","first-page":"22","article-title":"Evaluation of eligibility criteria used to identify patients for medication therapy management services: a retrospective cohort study in a medicare advantage Part D population","volume":"22","author":"Lee","year":"2016","journal-title":"J Manag Care Spec Pharm"},{"issue":"4","key":"10.1016\/j.sapharm.2019.11.008_bib41","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/jep.12737","article-title":"Evaluation of drug-related problems in older polypharmacy primary care patients","volume":"23","author":"Kova\u010devi\u0107","year":"2017","journal-title":"J Eval Clin Pract"},{"issue":"6","key":"10.1016\/j.sapharm.2019.11.008_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0156304","article-title":"Priority setting and influential factors on acceptance of pharmaceutical recommendations in collaborative medication reviews in an ambulatory care setting - analysis of a cluster randomized controlled trial (WestGem-study)","volume":"11","author":"Rose","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.sapharm.2019.11.008_bib43","first-page":"573","article-title":"Associations between chronic disease, polypharmacy, and medication-related problems among medicare beneficiaries","volume":"25","author":"Almod\u00f3var","year":"2019","journal-title":"J Manag Care Spec Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2019.11.008_bib44","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/eurpub\/cky105","article-title":"Contribution of chronic conditions to gender disparities in health expectancies in Belgium, 2001, 2004 and 2008","volume":"29","author":"Yokota","year":"2019","journal-title":"Eur J Public Health"},{"issue":"3","key":"10.1016\/j.sapharm.2019.11.008_bib45","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/fampra\/cmu015","article-title":"Detected health and well-being problems following comprehensive geriatric assessment during a home visit among community-dwelling older people: who benefits most?","volume":"31","author":"Stijnen","year":"2014","journal-title":"Fam Pract"},{"issue":"2","key":"10.1016\/j.sapharm.2019.11.008_bib46","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1365-2125.2006.02698.x","article-title":"Which drugs cause preventable admissions to hospital? A systematic review","volume":"63","author":"Howard","year":"2006","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.sapharm.2019.11.008_bib47","first-page":"66","article-title":"Should eligibility for medication therapy management Be based on drug adherence?","volume":"20","author":"Stuart","year":"2014","journal-title":"J Manag Care Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2019.11.008_bib48","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11096-017-0571-y","article-title":"Drug-related problems identified during geriatric medication review in the community pharmacy","volume":"40","author":"Rhalimi","year":"2018","journal-title":"Int J Clin Pharm"},{"issue":"3","key":"10.1016\/j.sapharm.2019.11.008_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2014-006376","article-title":"Determination of risk factors for drug-related problems: a multidisciplinary triangulation process","volume":"5","author":"Kaufmann","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.sapharm.2019.11.008_bib50","series-title":"Developing and Evaluating Complex Interventions: The New Medical Research Council Guidance","author":"Craig","year":"2008"},{"key":"10.1016\/j.sapharm.2019.11.008_bib51","article-title":"Studying the impact of a medication use evaluation by the community pharmacist (Simenon): patient-reported outcome measures","author":"Wuyts","year":"2019","journal-title":"Res Soc Adm Pharm"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741119305728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741119305728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:19:27Z","timestamp":1761556767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741119305728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1551741119305728"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2019.11.008","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Studying the impact of a medication use evaluation by the community pharmacist (Simenon): Drug-related problems and associated variables","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2019.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}